Prophylaxis of cerebrovascular events in dementia @entity1 receiving XXXX .

@entity1 @entity137 @entity1090
OBJECTIVE: To determine if differences exist in prescribing for @entity137 ( @entity137 ) prophylaxis between residents receiving @entity1090 therapy and those with no antipsychotic therapy. DESIGN: Retrospective, multicentered, cross-sectional study. SETTING: Ten long-term care facilities. @entity1 : A total of 200 residents residing in skilled nursing facilities. The study group (n = 95) included residents with a risk factor for a @entity137 receiving @entity1090 . The control group (n = 105) consisted of residents with a risk factor for a @entity137 and not receiving antipsychotic therapy. MEASUREMENTS: Data collected included @entity1 age, gender, risk factor for @entity137 , and @entity137 . Statistics were performed using Chi-squared tests. RESULTS: Fifty-six percent of the study group was not on an agent for @entity137 , compared with 36% of the control group. CONCLUSION: This study demonstrated with statistical significance that @entity137 was less likely in the @entity1090 group. We are implementing a pharmacist-driven initiative to add antiplatelet therapies in all @entity1 who have at least one risk factor for @entity137 .
